MarketPeel
Insider Trading Intelligence
HA

Harry W. JR Alcorn

DMAC
SVP, CLINICAL OPERATIONS · DIAMEDICA THERAPEUTICS INC. · CIK 0001186761
FILING MIX · LIFETIME100%/0%
BUYS
6
SELLS
0
TOTAL VALUE
$121.0K
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
43,582
AVG SELL PX
TRADE KIND
SHOWING 6 / 6
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Harry W. JR Alcorn, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+75.00%+12.08%-0.43%+12.51%+16.04%
14d4+100.00%+17.97%+0.21%+17.76%+21.32%
30d4+100.00%+14.71%+0.12%+14.59%+17.42%
60d4+100.00%+19.50%+1.23%+18.27%+24.55%
90d4+75.00%+16.16%+4.63%+11.53%+17.58%
180d4+0.00%-17.83%-2.16%-15.67%-9.54%
1y4+0.00%-48.69%-4.78%-43.91%-41.58%
2y4+0.00%-8.86%+1.65%-10.50%-7.78%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
DMAC · 43,582 shares · as of Sep 15, 2021
015,00030,00045,00060,0002021SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
FLOW · 6 buys / 0 sellsCOVERAGE · 6 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
DMAC
DIAMEDICA THERAPEUTICS INC.
PURCHASE
SVP, Clinical Operations
15,000$3.80$57.0K43,582Sep 15, 2021Sep 15, 2021View →
DMAC
DIAMEDICA THERAPEUTICS INC.
PURCHASE
Senior VP, Clinical Operations
399$3.07$1.2K399Aug 16, 2021Aug 16, 2021View →
DMAC
DIAMEDICA THERAPEUTICS INC.
PURCHASE
Senior VP, Clinical Operations
20,000$3.09$61.8K28,260Aug 16, 2021Aug 16, 2021View →
DMAC
DIAMEDICA THERAPEUTICS INC.
PURCHASE
Senior VP, Clinical Operations
322$3.06$98528,582Aug 16, 2021Aug 16, 2021View →
DMAC
DIAMEDICA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
60,00060,000Jul 28, 2021Jul 29, 2021View →
DMAC
DIAMEDICA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
35,00035,000Jun 1, 2020Jun 2, 2020View →
Other insiders · DMAC
Loading peer insiders…
About this filer
CIK 0001186761
ROLE
SVP, Clinical Operations
PRIMARY
DMAC
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001186761DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback